{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T23:51:49Z","timestamp":1774569109225,"version":"3.50.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,3,4]],"date-time":"2019-03-04T00:00:00Z","timestamp":1551657600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Indian J Hematol Blood Transfus"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1007\/s12288-019-01108-7","type":"journal-article","created":{"date-parts":[[2019,3,4]],"date-time":"2019-03-04T05:59:47Z","timestamp":1551679187000},"page":"655-661","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Impact of Pre-transplant and Post-transplant Remission Status of Patients on Survival in Newly Diagnosed Multiple Myeloma"],"prefix":"10.1007","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5687-8531","authenticated-orcid":false,"given":"Rafiye","family":"Ciftciler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hakan","family":"Goker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yahya","family":"Buyukas\u0131k","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elifcan","family":"Aladag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haluk","family":"Demiroglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,3,4]]},"reference":[{"issue":"1","key":"1108_CR1","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.ejca.2009.07.006","volume":"46","author":"M Schaapveld","year":"2010","unstructured":"Schaapveld M, Visser O, Siesling S, Schaar CG, Zweegman S, Vellenga E (2010) Improved survival among younger but not among older patients with Multiple Myeloma in the Netherlands, a population-based study since 1989. Eur J Cancer 46(1):160\u2013169","journal-title":"Eur J Cancer"},{"issue":"5","key":"1108_CR2","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1038\/leu.2013.313","volume":"28","author":"SK Kumar","year":"2014","unstructured":"Kumar SK, Dispenzieri A, Lacy MQ, Gertz MA, Buadi FK, Pandey S et al (2014) Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients. Leukemia 28(5):1122","journal-title":"Leukemia"},{"issue":"20","key":"1108_CR3","doi-asserted-by":"publisher","first-page":"3076","DOI":"10.1182\/blood-2014-09-568915","volume":"125","author":"P Moreau","year":"2015","unstructured":"Moreau P, Attal M, Facon T (2015) Frontline therapy of multiple myeloma. Blood 125(20):3076\u20133084","journal-title":"Blood"},{"issue":"20","key":"1108_CR4","doi-asserted-by":"publisher","first-page":"3085","DOI":"10.1182\/blood-2014-11-568923","volume":"125","author":"AK Nooka","year":"2015","unstructured":"Nooka AK, Kastritis E, Dimopoulos MA, Lonial S (2015) Treatment options for relapsed and refractory multiple myeloma. Blood 125(20):3085\u20133099","journal-title":"Blood"},{"key":"1108_CR5","doi-asserted-by":"crossref","unstructured":"Attal M, Lauwers-Cances V, Hulin C, Facon T, Caillot D, Escoffre M et al (2015) Autologous transplantation for multiple myeloma in the era of new drugs: a phase III study of the Intergroupe Francophone Du Myelome (IFM\/DFCI 2009 Trial). Am Soc Hematol","DOI":"10.1182\/blood.V126.23.391.391"},{"issue":"11","key":"1108_CR6","doi-asserted-by":"publisher","first-page":"3041","DOI":"10.1182\/blood-2010-08-300863","volume":"117","author":"P Moreau","year":"2010","unstructured":"Moreau P, Attal M, P\u00e9gouri\u00e9 B, Planche L, Hulin C, Facon T et al (2010) Achievement of VGPR to induction therapy is an important prognostic factor for longer PFS in the IFM 2005\u201301 trial. Blood 117(11):3041\u20133044","journal-title":"Blood"},{"issue":"36","key":"1108_CR7","doi-asserted-by":"publisher","first-page":"4529","DOI":"10.1200\/JCO.2013.49.0086","volume":"31","author":"P Kapoor","year":"2013","unstructured":"Kapoor P, Kumar SK, Dispenzieri A, Lacy MQ, Buadi F, Dingli D et al (2013) Importance of achieving stringent complete response after autologous stem-cell transplantation in multiple myeloma. J Clin Oncol 31(36):4529","journal-title":"J Clin Oncol"},{"issue":"8","key":"1108_CR8","doi-asserted-by":"publisher","first-page":"e328","DOI":"10.1016\/S1470-2045(16)30206-6","volume":"17","author":"S Kumar","year":"2016","unstructured":"Kumar S, Paiva B, Anderson KC, Durie B, Landgren O, Moreau P et al (2016) International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma. Lancet Oncol 17(8):e328\u2013e346","journal-title":"Lancet Oncol"},{"issue":"1","key":"1108_CR9","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.bbmt.2012.08.009","volume":"19","author":"M Blanes","year":"2013","unstructured":"Blanes M, Lahuerta JJ, Gonz\u00e1lez JD, Ribas P, Solano C, Alegre A et al (2013) Intravenous busulfan and melphalan as a conditioning regimen for autologous stem cell transplantation in patients with newly diagnosed multiple myeloma: a matched comparison to a melphalan-only approach. Biol Blood Marrow Transplant 19(1):69\u201374","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"1108_CR10","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/sj.bmt.1704728","volume":"35","author":"M Krejci","year":"2005","unstructured":"Krejci M, Buchler T, Hajek R, Svobodnik A, Krivanova A, Pour L et al (2005) Prognostic factors for survival after autologous transplantation: a single centre experience in 133 multiple yeloma patients. Bone Marrow Transplant 35(2):159","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"1108_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/sj.bmt.1705194","volume":"37","author":"P Hari","year":"2006","unstructured":"Hari P, Pasquini M, Vesole D (2006) Cure of multiple myeloma\u2014more hype, less reality. Bone Marrow Transplant 37(1):1","journal-title":"Bone Marrow Transplant"},{"issue":"12","key":"1108_CR12","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1038\/sj.bmt.1705799","volume":"40","author":"J Mehta","year":"2007","unstructured":"Mehta J, Singhal S (2007) High-dose chemotherapy and autologous hematopoietic stem cell transplantation in myeloma patients under the age of 65 years. Bone Marrow Transplant 40(12):1101","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"1108_CR13","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/sj.bmt.1704562","volume":"34","author":"R Alexanian","year":"2004","unstructured":"Alexanian R, Weber D, Delasalle K, Handy B, Champlin R, Giralt S (2004) Clinical outcomes with intensive therapy for patients with primary resistant multiple myeloma. Bone Marrow Transplant 34(3):229","journal-title":"Bone Marrow Transplant"},{"issue":"8","key":"1108_CR14","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1038\/leu.2008.40","volume":"22","author":"B Barlogie","year":"2008","unstructured":"Barlogie B, Van Rhee F, Shaughnessy J Jr, Anaissie E, Crowley J (2008) Making progress in treating multiple myeloma with total therapies: issue of complete remission and more. Leukemia 22(8):1633","journal-title":"Leukemia"},{"issue":"8","key":"1108_CR15","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/sj.bmt.1705307","volume":"37","author":"D O'shea","year":"2006","unstructured":"O'shea D, Giles C, Terpos E, Perz J, Politou M, Sana V et al (2006) Predictive factors for survival in myeloma patients who undergo autologous stem cell transplantation: a single-centre experience in 211 patients. Bone Marrow Transplant 37(8):731","journal-title":"Bone Marrow Transplant"},{"issue":"9","key":"1108_CR16","first-page":"844","volume":"84","author":"I Majolino","year":"1999","unstructured":"Majolino I, Vignetti M, Meloni G, Vegna ML, Scim\u00e8 R, Tringali S et al (1999) Autologous transplantation in multiple myeloma: a GITMO retrospective analysis on 290 patients Gruppo Italiano Trapianti di Midollo Osseo. Haematologica 84(9):844\u2013852","journal-title":"Haematologica"},{"issue":"9","key":"1108_CR17","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1200\/JCO.2004.06.144","volume":"22","author":"C Morris","year":"2004","unstructured":"Morris C, Iacobelli S, Brand R, Bjorkstrand B, Drake M, Niederwieser D et al (2004) Benefit and timing of second transplantations in multiple myeloma: clinical findings and methodological limitations in a European Group for Blood and Marrow Transplantation registry study. J Clin Oncol 22(9):1674\u20131681","journal-title":"J Clin Oncol"},{"issue":"4","key":"1108_CR18","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.bbmt.2008.12.512","volume":"15","author":"JS Kim","year":"2009","unstructured":"Kim JS, Kim K, Cheong J-W, Min YH, Suh C, Kim H et al (2009) Complete remission status before autologous stem cell transplantation is an important prognostic factor in patients with multiple myeloma undergoing upfront single autologous transplantation. Biol Blood Marrow Transplant 15(4):463\u2013470","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"1108_CR19","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/sj.bmt.1704313","volume":"33","author":"E Nadal","year":"2004","unstructured":"Nadal E, Gine E, Blad\u00e9 J, Esteve J, Rosi\u00f1ol L, Fernandez-Aviles F et al (2004) High-dose therapy\/autologous stem cell transplantation in patients with chemosensitive multiple myeloma: predictors of complete remission. Bone Marrow Transplant 33(1):61","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"1108_CR20","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/sj.bmt.1704545","volume":"34","author":"S Kumar","year":"2004","unstructured":"Kumar S, Lacy M, Dispenzieri A, Rajkumar S, Fonseca R, Geyer S et al (2004) High-dose therapy and autologous stem cell transplantation for multiple myeloma poorly responsive to initial therapy. Bone Marrow Transplant 34(2):161","journal-title":"Bone Marrow Transplant"},{"issue":"10","key":"1108_CR21","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/sj.bmt.1703717","volume":"30","author":"S Singhal","year":"2002","unstructured":"Singhal S, Powles R, Sirohi B, Treleaven J, Kulkarni S, Mehta J (2002) Response to induction chemotherapy is not essential to obtain survival benefit from high-dose melphalan and autotransplantation in myeloma. Bone Marrow Transplant 30(10):673","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"1108_CR22","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.bbmt.2014.10.023","volume":"21","author":"R Vij","year":"2015","unstructured":"Vij R, Kumar S, Zhang M-J, Zhong X, Huang J, Dispenzieri A et al (2015) Impact of pretransplant therapy and depth of disease response before autologous transplantation for multiple myeloma. Biol Blood Marrow Transplant 21(2):335\u2013341","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"1108_CR23","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1046\/j.1365-2141.2002.03231.x","volume":"116","author":"G Tricot","year":"2002","unstructured":"Tricot G, Spencer T, Sawyer J, Spoon D, Desikan R, Fassas A et al (2002) Predicting long-term (\u2265 5 years) event-free survival in multiple myeloma patients following planned tandem autotransplants. Br J Haematol 116(1):211\u2013217","journal-title":"Br J Haematol"}],"container-title":["Indian Journal of Hematology and Blood Transfusion"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12288-019-01108-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12288-019-01108-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12288-019-01108-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,2]],"date-time":"2020-03-02T19:22:06Z","timestamp":1583176926000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12288-019-01108-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,4]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["1108"],"URL":"https:\/\/doi.org\/10.1007\/s12288-019-01108-7","relation":{},"ISSN":["0971-4502","0974-0449"],"issn-type":[{"value":"0971-4502","type":"print"},{"value":"0974-0449","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,4]]},"assertion":[{"value":"22 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors of this paper have no conflict of interests, including specific financial interests, relationships, and\/or affiliations relevant to the subject matter or materials included. The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All of the ethical considerations had been strictly followed in accordance with the 1964 Helsinki declaration. As a standard care\/action of the hospitals of the our tertiary care center, it has been recognized from the patient records that all of the studied patients had given informed consents at the time of hospitalization and before the administration of chemotherapy and other relevant diagnostic\/therapeutic standard of care.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}